Cargando…
Genomic NGFB variation and multiple sclerosis in a case control study
BACKGROUND: Nerve growth factor β (NGFB) is involved in cell proliferation and survival, and it is a mediator of the immune response. ProNGF, the precursor protein of NGFB, has been shown to induce cell death via interaction with the p75 neurotrophin receptor. In addition, this neurotrophin is diffe...
Autores principales: | , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2613874/ https://www.ncbi.nlm.nih.gov/pubmed/19063739 http://dx.doi.org/10.1186/1471-2350-9-107 |
_version_ | 1782163201947860992 |
---|---|
author | Akkad, Denis A Kruse, Niels Arning, Larissa Gold, Ralf Epplen, Jörg T |
author_facet | Akkad, Denis A Kruse, Niels Arning, Larissa Gold, Ralf Epplen, Jörg T |
author_sort | Akkad, Denis A |
collection | PubMed |
description | BACKGROUND: Nerve growth factor β (NGFB) is involved in cell proliferation and survival, and it is a mediator of the immune response. ProNGF, the precursor protein of NGFB, has been shown to induce cell death via interaction with the p75 neurotrophin receptor. In addition, this neurotrophin is differentially expressed in males and females. Hence NGFB is a good candidate to influence the course of multiple sclerosis (MS), much like in the murine model of experimental autoimmune encephalomyelitis (EAE). METHODS: Ten single nucleotide polymorphisms (SNPs) were genotyped in the NGFB gene in up to 1120 unrelated MS patients and 869 controls. Expression analyses were performed for selected MS patients in order to elucidate the possible functional relevance of the SNPs. RESULTS: Significant association of NGFB variations with MS is evident for two SNPs. NGFB mRNA seems to be expressed in sex- and disease progression-related manner in peripheral blood mononuclear cells. CONCLUSION: NGFB variation and expression levels appear as modulating factors in the development of MS. |
format | Text |
id | pubmed-2613874 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-26138742009-01-06 Genomic NGFB variation and multiple sclerosis in a case control study Akkad, Denis A Kruse, Niels Arning, Larissa Gold, Ralf Epplen, Jörg T BMC Med Genet Research Article BACKGROUND: Nerve growth factor β (NGFB) is involved in cell proliferation and survival, and it is a mediator of the immune response. ProNGF, the precursor protein of NGFB, has been shown to induce cell death via interaction with the p75 neurotrophin receptor. In addition, this neurotrophin is differentially expressed in males and females. Hence NGFB is a good candidate to influence the course of multiple sclerosis (MS), much like in the murine model of experimental autoimmune encephalomyelitis (EAE). METHODS: Ten single nucleotide polymorphisms (SNPs) were genotyped in the NGFB gene in up to 1120 unrelated MS patients and 869 controls. Expression analyses were performed for selected MS patients in order to elucidate the possible functional relevance of the SNPs. RESULTS: Significant association of NGFB variations with MS is evident for two SNPs. NGFB mRNA seems to be expressed in sex- and disease progression-related manner in peripheral blood mononuclear cells. CONCLUSION: NGFB variation and expression levels appear as modulating factors in the development of MS. BioMed Central 2008-12-08 /pmc/articles/PMC2613874/ /pubmed/19063739 http://dx.doi.org/10.1186/1471-2350-9-107 Text en Copyright © 2008 Akkad et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Akkad, Denis A Kruse, Niels Arning, Larissa Gold, Ralf Epplen, Jörg T Genomic NGFB variation and multiple sclerosis in a case control study |
title | Genomic NGFB variation and multiple sclerosis in a case control study |
title_full | Genomic NGFB variation and multiple sclerosis in a case control study |
title_fullStr | Genomic NGFB variation and multiple sclerosis in a case control study |
title_full_unstemmed | Genomic NGFB variation and multiple sclerosis in a case control study |
title_short | Genomic NGFB variation and multiple sclerosis in a case control study |
title_sort | genomic ngfb variation and multiple sclerosis in a case control study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2613874/ https://www.ncbi.nlm.nih.gov/pubmed/19063739 http://dx.doi.org/10.1186/1471-2350-9-107 |
work_keys_str_mv | AT akkaddenisa genomicngfbvariationandmultiplesclerosisinacasecontrolstudy AT kruseniels genomicngfbvariationandmultiplesclerosisinacasecontrolstudy AT arninglarissa genomicngfbvariationandmultiplesclerosisinacasecontrolstudy AT goldralf genomicngfbvariationandmultiplesclerosisinacasecontrolstudy AT epplenjorgt genomicngfbvariationandmultiplesclerosisinacasecontrolstudy |